Company registration number 09594659 (England and Wales)
HILLS PHARMA RESEARCH LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2026
PAGES FOR FILING WITH REGISTRAR
HILLS PHARMA RESEARCH LIMITED
BALANCE SHEET
AS AT
31 MARCH 2026
31 March 2026
- 1 -
31 March 2026
31 May 2025
£
£
£
£
Current assets
398
1,648
Creditors: amounts falling due within one year
(3,302)
(1,544)
Net current (liabilities)/assets
(2,904)
104
Net (liabilities)/assets
(2,904)
104
Capital and reserves
(2,904)
104
Notes to the financial statements
1
Employees
The average number of persons, including directors, employed by the company during the period was as follows:
2026
2025
Number
Number
Employees
0
1
Hills Pharma Research Limited is a private company limited by shares incorporated in England and Wales. The registered office is 303 Boxley Road, Penenden Heath, Maidstone, Kent, UK, ME14 2HD.
For the period ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.
These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime', and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved and signed by the director and authorised for issue on 11 June 2026
Mrs N Hills
Director
Company registration number 09594659 (England and Wales)